Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 11—November 2014
Dispatch

Hepatitis E Virus Infections in Blood Donors, France

Pierre Gallian, Sébastien Lhomme, Yves Piquet, Karine Sauné, Florence Abravanel, Azzedine Assal, Pierre Tiberghien, and Jacques IzopetComments to Author 
Author affiliations: École des Hautes Études en Santé Publique, Marseille, France (P. Gallian); Etablissement Français du Sang Alpes Méditerranée, Marseille (P. Gallian); Institut National de la Santé et de la Recherche Médicale Unite 1043, Toulouse, France (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Université Toulouse III Paul-Sabatier, Toulouse (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Institut Fédératif de Biologie, Toulouse (S. Lhomme, K. Sauné, F. Abravanel, J. Izopet); Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France (Y. Piquet, A. Assal); Etablissement Français du Sang, La Plaine Saint-Denis, France (P. Tiberghien); Université de Franche-Comté, Besançon, France (P. Tiberghien)

Main Article

Table 2

Characteristics of 24 blood donors with HEV RNA–positive archived blood samples, France, November 27, 2912–December 1, 2013*

Donor/age, y/sex HEV RNA, IU/mL Genotype IgG against HEV IgM against HEV
1/32/M 1,903 3f
2/37/M 128,700 3f
3/60/M 1,404,100 3f
4/52/F 179,400 3c
5/55/M 102,960 3c
6/59/M 19,344 3f + +
7/41/M 1,333 3f
8/61/M 391,560 3c
9/28/M 2,293 3f
10/40/M 8,502 3
11/57/M 803,400 3f
12/37/M 5,155,800 3c
13/37/M 1,981 3f
14/58/M 6,208 3c
15/53/M 13,728 3c
16/59/M 111,696 3f
17/44/M 61,932 3c
18/54/M 258,180 3c
19/34/M 4,852 3f
20/41/M 3,994 3f
21/48/M 468 NT + +
22/55/M 306,540 3f
23/25/M 4,118 3f
24/57/M 2,355 NT

*HEV, hepatitis E virus; –, negative; +, positive; NT, not tested because of insufficient material.

Main Article

Page created: October 17, 2014
Page updated: October 17, 2014
Page reviewed: October 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external